Children aged 6 months to <5 years are recommended to receive COVID-19 vaccine if they have severe immunocompromise, disability or complex/multiple health conditions that increase their risk of severe COVID-19
Children aged 6 months to <5 years are recommended to receive COVID-19 vaccine in a 3-dose schedule, with each dose 8 weeks apart. Severely immunocompromised children do not require an additional (4th) primary dose.
Further doses are not currently recommended for children aged 6 months to <5 years.
Comirnaty Original is the only formulation currently registered for this age group.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.